← Back to Search

Post-Operative Activity Restriction Duration for Stress Urinary Incontinence

N/A
Waitlist Available
Led By Oz Harmanli, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients who are ambulatory and scheduled for midurethral sling placement surgery only for treatment of stress urinary incontinence
At least 18 years of age
Must not have
Patients who are unable to read, understand, or complete study documents in English or Spanish
Patients who are unable to commit to 6 weeks of no heavy lifting (20 lbs)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks, 6 months, and 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare outcomes and satisfaction for patients who have different post-operative restrictions following a midurethral sling procedure.

Who is the study for?
This trial is for ambulatory patients at least 18 years old who are scheduled for midurethral sling surgery to treat stress urinary incontinence. Participants must be able to understand and complete study documents in English or Spanish, and commit to not lifting heavy objects (over 20 lbs) for 6 weeks.
What is being tested?
The study compares two different durations of activity restrictions after midurethral sling surgery: one group will have a 3-week restriction, while the other will have a 6-week restriction. The focus is on postoperative outcomes and patient satisfaction.
What are the potential side effects?
Since this trial involves post-surgical care instructions rather than medication, it does not directly test interventions with side effects. However, general surgical risks may include discomfort, infection risk at the incision site, or complications related to reduced activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk and am scheduled for a specific surgery to treat stress urinary incontinence.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot read or understand English or Spanish well enough to complete study documents.
Select...
I can avoid heavy lifting (20 lbs) for 6 weeks.
Select...
I am having surgery for pelvic organ prolapse not including a midurethral sling.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks, 6 months, and 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks, 6 months, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in urogenital distress inventory (UDI) stress score
Secondary study objectives
Activity Assessment Scale (AAS)
Change in Patient Satisfaction Post-Operative Questionnaire
Change in cough stress test
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: 6-week post-operative activity restrictionExperimental Treatment1 Intervention
Participants will be given postoperative instructions which include refraining from lifting anything over 20 pounds, avoiding strenuous exercise, running, or performing high-impact aerobic activities for 6-weeks post operation.
Group II: 3-week post-operative activity restrictionExperimental Treatment1 Intervention
Participants will be given postoperative instructions which include refraining from lifting anything over 20 pounds, avoiding strenuous exercise, running, or performing high-impact aerobic activities for 3-weeks post operation.

Find a Location

Who is running the clinical trial?

Boston Scientific CorporationIndustry Sponsor
743 Previous Clinical Trials
857,190 Total Patients Enrolled
Yale UniversityLead Sponsor
1,920 Previous Clinical Trials
3,031,278 Total Patients Enrolled
Oz Harmanli, MDPrincipal InvestigatorYale University
2 Previous Clinical Trials
137 Total Patients Enrolled

Media Library

3-week post-operative activity restriction Clinical Trial Eligibility Overview. Trial Name: NCT04817839 — N/A
Stress Incontinence Research Study Groups: 3-week post-operative activity restriction, 6-week post-operative activity restriction
Stress Incontinence Clinical Trial 2023: 3-week post-operative activity restriction Highlights & Side Effects. Trial Name: NCT04817839 — N/A
3-week post-operative activity restriction 2023 Treatment Timeline for Medical Study. Trial Name: NCT04817839 — N/A
~0 spots leftby Dec 2024